ברידיון

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

SUGAMMADEX

MAH:

MERCK SHARP & DOHME (ISRAEL - 1996) COMPANY LTD, ISRAEL

ATC_code:

V03AB35

pharmaceutical_form:

תמיסה להזרקה

composition:

SUGAMMADEX 100 MG/ML

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

N.V. ORGANON, THE NETHERLANDS

therapeutic_group:

SUGAMMADEX

therapeutic_area:

SUGAMMADEX

therapeutic_indication:

Reversal of neuromuscular blockade induced by rocuronium or vecuronium.

authorization_date:

2014-12-31